Evidence map›Paper›PMID 28729000›Full record

Trial reportThe Journal of allergy and clinical immunology2018

Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung.

Stéphane Mouraux, Eric Bernasconi, Céline Pattaroni, Angela Koutsokera, John-David Aubert, Johanna Claustre, Christophe Pison, Pierre-Joseph Royer, Antoine Magnan, Romain Kessler and 5 more

Registry-linked trialAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03545919 (Clinical Significance of Community-acquired Respiratory Virus Infection and Longitudinal Analysis of the Lung Microbiome in Lung Transplantation), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03545919 unknown statusnot on this map

Clinical Significance of Community-acquired Respiratory Virus Infection and Longitudinal Analysis of the Lung Microbiome in Lung Transplantation

TypeobservationalSponsorCapital Medical UniversityRan2018 to 2022Enrolled100ConditionsLung Transplant Infection, Lung Transplant Rejection
3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Beyond the organ: lung microbiome shapes transplant indications and outcomes.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2024
    Review
  6. Review
  7. Article
  8. Observational
  9. Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023
    Article
  10. The dynamic lung microbiome in health and disease.Nature reviews. Microbiology · 2023
    Review
  11. Review
  12. Review
  13. The Lung Allograft Microbiome Associates with Pepsin, Inflammation, and Primary Graft Dysfunction.American journal of respiratory and critical care medicine · 2022
    Article
  14. Lung Allograft Dysfunction: Does Aspiration Hold the Key?American journal of respiratory and critical care medicine · 2022
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Stéphane MourauxService de Pneumologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Eric BernasconiService de Pneumologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. Electronic address: Eric.Bernasconi@chuv.ch.
Céline PattaroniService de Pneumologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Angela KoutsokeraService de Pneumologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
John-David AubertService de Pneumologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Johanna ClaustreClinique Universitaire de Pneumologie, Pôle Thorax et Vaisseaux, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France; Université Grenoble Alpes, Grenoble, France; Institut National de la Santé et de la Recherche Médicale 1055, Saint Martin d'Hèes, France.
Christophe PisonClinique Universitaire de Pneumologie, Pôle Thorax et Vaisseaux, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France; Université Grenoble Alpes, Grenoble, France; Institut National de la Santé et de la Recherche Médicale 1055, Saint Martin d'Hèes, France.
Pierre-Joseph RoyerL'institut du Thorax, Service de Pneumologie, Centre Hospitalier Universitaire de Nantes, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Université de Nantes, Nantes, France.
Antoine MagnanL'institut du Thorax, Service de Pneumologie, Centre Hospitalier Universitaire de Nantes, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Université de Nantes, Nantes, France.
Romain KesslerService de Pneumologie, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.
Christian BendenDivision of Pulmonology, University Hospital Zurich, Zurich, Switzerland.
Paola M SoccalDivision of Pulmonary Medicine, Geneva University Hospitals, Geneva, Switzerland.
Benjamin J MarslandService de Pneumologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Laurent P NicodService de Pneumologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
SysCLAD Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHomeostatic turnover of the extracellular matrix conditions the structure and function of the healthy lung. In lung transplantation, long-term management remains limited by chronic lung allograft dysfunction, an umbrella term used for a heterogeneous entity ultimately associated with pathological airway and/or parenchyma remodeling.

objectiveThis study assessed whether the local cross-talk between the pulmonary microbiota and host cells is a key determinant in the control of lower airway remodeling posttransplantation.

methodsMicrobiota DNA and host total RNA were isolated from 189 bronchoalveolar lavages obtained from 116 patients post lung transplantation. Expression of a set of 11 genes encoding either matrix components or factors involved in matrix synthesis or degradation (anabolic and catabolic remodeling, respectively) was quantified by real-time quantitative PCR. Microbiota composition was characterized using 16S ribosomal RNA gene sequencing and culture.

resultsWe identified 4 host gene expression profiles, among which catabolic remodeling, associated with high expression of metallopeptidase-7, -9, and -12, diverged from anabolic remodeling linked to maximal thrombospondin and platelet-derived growth factor D expression. While catabolic remodeling aligned with a microbiota dominated by proinflammatory bacteria (eg, Staphylococcus, Pseudomonas, and Corynebacterium), anabolic remodeling was linked to typical members of the healthy steady state (eg, Prevotella, Streptococcus, and Veillonella). Mechanistic assays provided direct evidence that these bacteria can impact host macrophage-fibroblast activation and matrix deposition.

conclusionsHost-microbes interplay potentially determines remodeling activities in the transplanted lung, highlighting new therapeutic opportunities to ultimately improve long-term lung transplant outcome.

Indexed as

BacteriaLungLung TransplantationAdultAirway RemodelingExtracellular MatrixFemaleFibroblastsHumansMacrophagesMaleMicrobiotaMiddle AgedSignal TransductionAirway remodelingfibroblastsmacrophagesmatrixmicrobiota

Identifiers

PMID28729000
PMCPMC5792246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.